Serial #79242770
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79242770 Trademark

Serial Number: 79242770 • Registration: 5772229

Serial #79242770 is a trademark filed by Chengdu Kanghong Pharmaceuticals Group Co., Ltd. on May 18, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Chengdu Kanghong Pharmaceuticals Group Co., Ltd. (7 trademarks)

No.36, Shuxi Rd.,
Sichuan , CN

Entity Type: 99

Trademark Details

Filing Date

May 18, 2018

Registration Date

June 11, 2019

Published for Opposition

March 26, 2019

Cancellation Date

December 26, 2025

Goods & Services

Tonics being medicines, namely, nutritional supplements for anti-fatigue, anti-aging, regulating the immune system, improving sleep, improving blood circulation, refection, relieving pressure and fatigue; medicines for human purposes, namely, for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinologic, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders, to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; anti-infective; anti-inflammatories; vaccines; medicinal drinks; medical tea, namely, slimming tea for medical purposes; capsules sold empty for medicines; pharmaceutical preparations, namely, pharmaceutical preparations used for the relief of pain and to reduce fever, for the prevention and/or treatment of cardiovascular diseases, hemophilia, metabolic diseases, cancer, multiple sclerosis, urologic diseases, sexual dysfunction, osteoporosis, and climacteric diseases, anticoagulants and platelet aggregation inhibitors, contraceptive preparations, analgesics, antipyretics, anti-inflammatory preparations, anti-septic preparations, medicated lip balm, anesthetic spray for topical use, astringents, pediculicides, decongestants, antifungal agents, anti-infective pharmaceutical preparations, antacids, cold preparations in the nature of preparations for treating colds, menstrual symptom treatment preparations and dermatologicals, vitamin and mineral supplements, calcium supplements, and for the treatment of ophthalmic diseases and conditions; chemical preparations, namely, for diagnosis and treatment of gastrointestinal disease, stomach illness, diseases of the immune system, eye disease, metabolic disease and tumors, and for the diagnosis of pregnancy; medicinal tea; crude drugs in the nature of natural supplements for the treatment of central nervous system diseases, namely, hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely, dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall-stone, ophthalmology system diseases, namely, wet Age-related Macular Degeneration (AMD), and other diseases, namely, fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy; prepared Chinese medicines, namely, Chinese patent medicine for the treatment of central nervous system diseases, namely, hypertension, hyperlipidemia, schizophrenia and melancholia, digestive system diseases, namely, dyspepsia, chronic gastritis, chronic lithogenous cholecystitis, chronic cholecystitis and gall stones, ophthalmologic system diseases, namely, wet Age-related Macular Degeneration (AMD), and other diseases, namely, fever, irritability, red eyes, mouth sores, sore throat, swollen gums, constipation, pharyngitis, tonsillitis, gingivitis, upper respiratory infection (URI), acute bronchitis, diabetes and nephropathy; biochemical medicines, namely, medicines for the treatment of cancer; medicinal liquor; radioactive medicines, namely, radioactive pharmaceutical preparations for the treatment of cancer; gases for medical purposes, namely, gases for diagnosis of medical conditions, anesthesia and treatment of hypoxia; disinfectants; solutions for contact lenses; nutritive substances for microorganisms for medical purposes; dietetic substances in the nature of food and beverages adapted for medical use; disinfectants for chemical toilets; preparations for destroying noxious animals; sanitary towels; dressings, medical; teeth filling material

Filing History

CANCELLED SECTION 71
Dec 26, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 11, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 9, 2024 NREP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 10, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 10, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 10, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 10, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 10, 2022 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 8, 2019 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Sep 23, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
Sep 23, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 11, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 11, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 26, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Mar 23, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 6, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 6, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 6, 2019 OP2R
ASSIGNED TO LIE
Feb 15, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 30, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 30, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 30, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 30, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 30, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2019 TROA
REFUSAL PROCESSED BY IB
Nov 17, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 19, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 15, 2018 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 11, 2018 REPR